Shineco, Inc. (SISI)

OTCMKTS · Delayed Price · Currency is USD
1.500
-2.420 (-61.73%)
At close: Oct 8, 2025
-61.73%
Market Cap3.53M
Revenue (ttm)9.60M
Net Income (ttm)-38.90M
Shares Out900.61K
EPS (ttm)-422.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume98,514
Average Volume94,017
Open1.020
Previous Close3.920
Day's Range1.010 - 2.140
52-Week Range0.500 - 271.500
Beta-0.83
RSI22.01
Earnings Daten/a

About Shineco

Shineco, Inc., through its subsidiaries, plants, processes, and distributes agricultural produce. The company also engages in the development, production, and distribution of diagnostic products and related medical devices; trading of fresh fruits; and processing, producing, and distribution of silk and silk fabrics, as well as other by-products. In addition, it operates a restaurant in Fuzhou. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. Shineco, Inc. was incorporated in 1997 and is based in Beijing,... [Read more]

Industry Farm Products
Founded 1997
Employees 119
Stock Exchange OTCMKTS
Ticker Symbol SISI
Full Company Profile

Financial Performance

In 2024, Shineco's revenue was $9.80 million, an increase of 1680.61% compared to the previous year's $550,476. Losses were -$22.45 million, 68.0% more than in 2023.

Financial Statements

News

Shineco (SISI) Secures $8.7M Contract for R&D in Biotech Innovation

Shineco (SISI) Secures $8.7M Contract for R&D in Biotech Innovation

26 days ago - GuruFocus

Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines

BEIJING , Sept. 12, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a developer and commercializer of induced pluripotent stem cell (iPSC) technology platforms, today an...

26 days ago - PRNewsWire

Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries

BEIJING , Sept. 10, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced tha...

4 weeks ago - PRNewsWire

Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth

BEIJING , Aug. 27, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered into a strateg...

6 weeks ago - PRNewsWire

Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform; Strategic Acquisition Expands Global Blockchain-Biotech Network

BEIJING , Aug. 20, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a leading innovator in induced pluripotent stem cell (iPSC) technology, today announced the execution o...

7 weeks ago - PRNewsWire

Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology

BEIJING , Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the establ...

2 months ago - PRNewsWire

Shineco, Inc. to Effect 50:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price BEIJING, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (Nasdaq:SISI) ("Shineco" or the "Company"), a provider of innov...

2 months ago - GlobeNewsWire

Shineco Announces Acquisition of Medical Device Company

The Acquisition is Expected to Create Immediate Synergies with the Company's Existing Medical Device Business  BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NA...

7 months ago - GlobeNewsWire

Future FinTech Announces the Appointment of Hu Li as the New CEO

NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technolo...

1 year ago - PRNewsWire

Shineco Announces Closing of $2 Million Underwritten Public Offering

Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced ...

1 year ago - GlobeNewsWire

Shineco Announces Pricing of $2 Million Underwritten Public Offering

Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced ...

1 year ago - GlobeNewsWire

Shineco Announces Proposed Underwritten Public Offering

Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced ...

1 year ago - GlobeNewsWire

Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today th...

1 year ago - GlobeNewsWire

Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million

BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today t...

1 year ago - GlobeNewsWire

Shineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging Population

BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that...

1 year ago - GlobeNewsWire

Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products

Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today tha...

1 year ago - GlobeNewsWire

Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry

BEIJING , May 1, 2024 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its subsid...

1 year ago - PRNewsWire

Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the C...

1 year ago - GlobeNewsWire

Shineco Announces the Appointment of Two New Executive Officers

BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its B...

2 years ago - GlobeNewsWire

Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition

SISI Anticipates the Roll-Out of Additional Restaurants to Develop a Chain of Healthy Food Restaurants BEIJING, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SIS...

2 years ago - GlobeNewsWire

Shineco to Increase R&D to Explore New High-Tech Medical Product Applications

The Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for New Products

2 years ago - GlobeNewsWire

Shineco Subsidiary Receives Marketing Approval from China's Regulatory Body for its Cardiac 5-Minute Test

Registration with the NMPA, China's Regulatory Equivalent to the FDA, is a Prerequisite to Marketing and Distribution

2 years ago - GlobeNewsWire

Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company

BEIJING, June 28, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that on Ju...

2 years ago - GlobeNewsWire

Shineco Subsidiary Registered as a Member of Pharmaceutical Chamber of Commerce

Association with the Chamber Will Improve Visibility and Could Lead to Potential Collaborations BEIJING, June 08, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a p...

2 years ago - GlobeNewsWire

Shineco, Inc. Subsidiary Receives Prior Approval Supplement from the NMPA Jiangsu Bureau for the Marketing Approval of “Cardiac 5-Minute Test”

BEIJING, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech prod...

3 years ago - GlobeNewsWire